4.8 Review

Cigarette smoking, nicotine dependence and anxiety disorders: a systematic review of population-based, epidemiological studies

Journal

BMC MEDICINE
Volume 10, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/1741-7015-10-123

Keywords

agoraphobia; anxiety disorder; cigarette smoking; epidemiology; generalized anxiety disorder; nicotine dependence; obsessive-compulsive disorder; panic disorder; post-traumatic stress disorder; specific phobia

Funding

  1. Brain and Behaviour Research Institute
  2. National Health and Medical Research Council
  3. Geelong Medical Research Foundation
  4. The University of Melbourne
  5. Ian Potter Foundation
  6. Eli Lilly
  7. NHMRC Training Fellowship [628912]
  8. Amgen
  9. Sanofi-Aventis
  10. Barwon Health
  11. Dairy Research and Development Corporation
  12. Ronald Geoffrey Arnott Foundation
  13. ANZ Charitable Trust
  14. American Society for Bone and Mineral Research
  15. Amgen (Europe) GmBH
  16. NHMRC
  17. NIH
  18. Cooperative Research Centre
  19. Simons Autism Foundation
  20. Cancer Council of Victoria
  21. Stanley Medical Research Foundation
  22. MBF
  23. Beyond Blue
  24. Bristol Myers Squibb
  25. Glaxo SmithKline
  26. Organon
  27. Novartis
  28. Mayne Pharma and Servier
  29. Australian Rotary Health
  30. Perpetual Trustees

Ask authors/readers for more resources

Background: Multiple studies have demonstrated that rates of smoking and nicotine dependence are increased in individuals with anxiety disorders. However, significant variability exists in the epidemiological literature exploring this relationship, including study design (cross-sectional versus prospective), the population assessed (random sample versus clinical population) and diagnostic instrument utilized. Methods: We undertook a systematic review of population-based observational studies that utilized recognized structured clinical diagnostic criteria (Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Classification of Diseases (ICD)) for anxiety disorder diagnosis to investigate the relationship between cigarette smoking, nicotine dependence and anxiety disorders. Results: In total, 47 studies met the predefined inclusion criteria, with 12 studies providing prospective information and 5 studies providing quasiprospective information. The available evidence suggests that some baseline anxiety disorders are a risk factor for initiation of smoking and nicotine dependence, although the evidence is heterogeneous and many studies did not control for the effect of comorbid substance use disorders. The identified evidence however appeared to more consistently support cigarette smoking and nicotine dependence as being a risk factor for development of some anxiety disorders (for example, panic disorder, generalized anxiety disorder), although these findings were not replicated in all studies. A number of inconsistencies in the literature were identified. Conclusions: Although many studies have demonstrated increased rates of smoking and nicotine dependence in individuals with anxiety disorders, there is a limited and heterogeneous literature that has prospectively examined this relationship in population studies using validated diagnostic criteria. The most consistent evidence supports smoking and nicotine dependence as increasing the risk of panic disorder and generalized anxiety disorder. The literature assessing anxiety disorders increasing smoking and nicotine dependence is inconsistent. Potential issues with the current literature are discussed and directions for future research are suggested.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available